Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenylacetate in Pediatric CNS Tumors
NCT00003241Phase 2Completed
- Sponsor
- Texas Children's Cancer and Hematology Center
- Start
- May 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium phenylacetate in brain tumor, sponsored by Texas Children's Cancer and Hematology Center. Started May 1998; status: completed.
02
Drugs
sodium phenylacetate
03
Conditions
brain tumor
Beyond the preview
Go deeper on NCT00003241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003241.